Richard Peluso, PhD

Richard retired from Merck as a Vice President at the end of 2018 where he had responsibility and leadership for all Vaccine Bioprocess Research and Development, and he held a similar role for Merck Biologics Bioprocess, R&D.  Prior to Merck, Richard was Vice President of Process Sciences and Manufacturing at Genovo and Targeted Genetics.

He received his B.A. in Biology from the University of Maryland Baltimore County and his Ph.D. from The Rockefeller University. After a post-doc at the UCSF and Vanderbilt University, Richard was a faculty member at Jefferson University, University of Minnesota, and Mt. Sinai School of Medicine. After leaving Merck, he formed RWP BioConsulting, LLC to bring his expertise and experience to serve the life science industries. He currently sits on the Editorial Board for the publication Human Gene Therapy.